R-Lume Injection: Malaria Medication

Introducing R-LUME

R-LUME offers a potent combination of Artemether 180mg and Lumefantrine 1080mg in a synergistic formulation, designed as a safe and effective treatment against uncomplicated malaria. Approved by WHO and USFDA, it is recognized for its efficacy in both resistant and sensitive strains of P. falciparum malaria.

Key Benefits

• Clinical Safety: Demonstrates no significant clinical toxicity, ensuring patient safety during treatment.
• Synergistic Formulation: Combines artemether and lumefantrine to kill malaria parasites and prevent further growth and spread.
• Effective Against Resistance: Proven efficacy in treating malaria caused by chloroquine-resistant parasites.
• Approved Standards: Endorsed by WHO and USFDA for its effectiveness in uncomplicated P. falciparum malaria.

Why Choose R-LUME?

• High Cure Rates: Successfully eradicates malaria parasites without risk of side effects.

Customized Dosage: Administered base d on body weight to ensure optimal treatment outcomes in pediatric patients.

Recommended Use

Dosage (Dosage by body weight)

• 22.8 gm/60 ml Artemether and Lumefantrine Powder for Oral Suspension
• R-LumeTM Oral Suspension
• For Paediatric Use Only

Dosage Guidelines

• Body Weight | Day 1 | Day 2 | Day 3
• 5KG | 7ml | 7ml | 7ml
• 7.5KG | 10ml | 10ml | 10ml
• 10KG | 14ml | 14ml | 14ml
• 15KG | 20ml | 20ml | 20ml

Conditions Treated

• Uncomplicated Malaria
• Chloroquine-resistant Malaria

R-LUME stands as a formidable weapon in the global fight against malaria, offering a safe and reliable treatment option.